Stock listing

Viatris Inc.

Selected listing: A2QAME · LSX · EUR · DE

Viatris Inc. (LS Exchange: A2QAME), Health Technology. Latest release Oct 5, 2026: Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026.

A2QAME:LSXEURDEUpdated September 25, 2026

Ticker: LS Exchange: A2QAME
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

About Viatris Inc.

The company focuses on providing access to medicines and improving patient health outcomes. Viatris is dedicated to delivering high-quality pharmaceutical products and services to meet the needs of patients globally.

Latest news from Viatris Inc.

Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026

October 4, 2026

Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026

October 5, 2026

Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive Year

September 29, 2026

Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive Year

September 28, 2026

Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome

September 16, 2026

All Viatris Inc. news →

Events

Replays

Viatris Inc. (VTRS) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 08:30 AM ET
Watch
Viatris Inc. (VTRS) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:30 AM ET
Watch
Viatris Inc. (VTRS) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:30 AM ET
Watch

Research Viatris Inc.

Viatris Inc. company profile

View the public company page for Viatris Inc. on 6ix.

Viatris Inc. news

Read company news and market updates connected to Viatris Inc..

Viatris Inc. investor events

Find investor webinars, events, and replay context for Viatris Inc..